MAY/JUNE 2015 | VOL I, ISSUE 5
CancerTherapyAdvisor.com
CancerTherapyAdvisor
A18 CME ACTIVITY
PCA3: What Is Its Role in Prostate Cancer Screening?
FEATURING Cancer Therapy Regimens and Oncology Drug Monographs from
An article on the detection of prostate cancer via a urine-based biomarker and other clinical information.
1 Bone Cancer 3 Brain Cancer 5 Breast Cancer 18 Endocrine Cancer
A27 FEATURE
22 Gastrointestinal Cancer
What Does “5-Year Survival” Really Mean in Patients with Breast cancer?
37 Genitourinary Cancer
45 Gynecologic Cancer 53 Head and Neck Cancer
A29 IN THE CLINIC
Determining the Right Dose: The Relationship Between Obesity and Chemotherapy
54 Hematologic Cancer 84 Lung Cancer 89 Sarcoma
MAY/JUNE 2015 | VOL I, ISSUE 5
A33 VIEWPOINT
90 Skin Cancer
Genetic Aberration Affects Response to Bortezomib in AL Amyloidosis
94 Associated Hematological
Disorders
Regimen included
A31 EXPERT PERSPECTIVE What to Consider When It Comes to Surgery in Elderly Patients With Cancer
CTA_Cover_May-June0615.indd 1
4/22/15 12:34 PM